Canine low dose dexamethasone suppression testing serves as a primary diagnostic tool for identifying hyperadrenocorticism, commonly known as Cushing's disease, in dogs. This endocrine disorder causes the adrenal glands to produce excessive cortisol, and early detection is vital for preventing secondary complications such as hypertension and diabetes. The test evaluates the integrity of the hypothalamic-pituitary-adrenal axis by measuring how effectively the body responds to an external dose of steroid.
Understanding the Physiology Behind the Test
To interpret the results accurately, one must understand the normal feedback loop governing cortisol production. In a healthy dog, the hypothalamus releases corticotropin-releasing hormone (CRH), which prompts the anterior pituitary to secrete adrenocorticotropic hormone (ACTH). ACTH then stimulates the adrenal glands to release cortisol; elevated cortisol levels subsequently signal the brain to halt further production. A low dose dexamethasone suppression test verifies that this shutdown mechanism is functioning correctly.
Procedure and Protocol
The procedure is relatively straightforward and typically performed on an outpatient basis. A veterinarian will draw a baseline blood sample to measure the initial cortisol level, administer a precise dose of dexamethasone, and schedule follow-up blood draws usually at 4 and 8 hours post-administration. It is critical that the dog arrives fasted, as food can influence glucose and lipid levels, potentially complicating the analysis of the cortisol response.
Step-by-Step Timeline
Initial blood draw to establish baseline cortisol.
Administration of low-dose dexamethasone intravenously or intramuscularly.
Second blood draw at the 4-hour mark.
Final blood draw at the 8-hour mark to assess suppression.
Interpreting the Results
Interpretation hinges on the percentage drop in cortisol levels. A healthy response involves suppression to less than 1.4 µg/dL (or a drop to 50% of baseline) at the 4-hour mark. If the cortisol level remains above this threshold, it indicates a lack of feedback inhibition, pointing strongly toward Cushing's disease. Conversely, a normal suppression suggests the dog is free of the condition or that an alternative issue is affecting the results.
Differentiating Test Variants
It is essential to distinguish the low dose test from the high dose variant. While the low dose identifies the presence of the disease, the high dose—administering a larger amount of dexamethasone—is primarily utilized to differentiate between pituitary-dependent and adrenal-dependent Cushing's. In pituitary-dependent cases, the high dose often triggers a temporary suppression, whereas adrenal tumors usually remain unresponsive regardless of the dosage.
Limitations and Considerations
No diagnostic test is infallible, and the low dose dexamethasone suppression test has specific limitations. False negatives can occur in dogs with atypical adrenal enzyme deficiencies or those suffering from non-adrenal illnesses. Furthermore, iatrogenic Cushing's caused by prior glucocorticoid treatment for allergies or inflammation can render the test invalid, as the body’s natural production pathway is already suppressed.
Clinical Significance for Canine Health
For the aging dog, subtle changes in appetite, panting, and abdominal distension are often dismissed as signs of old age. This test provides concrete data to confirm or rule out hyperadrenocorticism, allowing for timely intervention. Managing the condition often involves medication like trilostane or mitotane, making early diagnosis instrumental in extending both the quantity and quality of the animal's life.
